These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25539124)

  • 1. Remission of recalcitrant dermatomyositis treated with ruxolitinib.
    Hornung T; Janzen V; Heidgen FJ; Wolf D; Bieber T; Wenzel J
    N Engl J Med; 2014 Dec; 371(26):2537-8. PubMed ID: 25539124
    [No Abstract]   [Full Text] [Related]  

  • 2. More on remission of recalcitrant dermatomyositis treated with ruxolitinib.
    Selva-O'Callaghan A; Trallero-Araguás E; Labrador-Horrillo M
    N Engl J Med; 2015 Mar; 372(13):1273-4. PubMed ID: 25806935
    [No Abstract]   [Full Text] [Related]  

  • 3. More on remission of recalcitrant dermatomyositis treated with ruxolitinib.
    Hornung T; Wolf D; Wenzel J
    N Engl J Med; 2015 Mar; 372(13):1274. PubMed ID: 25806934
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of dermatomyositis with ruxolitinib.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2016 Jul; 29(4):285. PubMed ID: 26448614
    [No Abstract]   [Full Text] [Related]  

  • 5. Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
    Vannucchi AM
    N Engl J Med; 2015 Apr; 372(17):1670-1. PubMed ID: 25901432
    [No Abstract]   [Full Text] [Related]  

  • 6. Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
    Hasselbalch HC; Bjørn ME
    N Engl J Med; 2015 Apr; 372(17):1670. PubMed ID: 25901433
    [No Abstract]   [Full Text] [Related]  

  • 7. JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.
    Pieri L; Pancrazzi A; Pacilli A; Rabuzzi C; Rotunno G; Fanelli T; Guglielmelli P; Fjerza R; Paoli C; Verstovsek S; Vannucchi AM
    Blood; 2015 May; 125(21):3352-3. PubMed ID: 25999444
    [No Abstract]   [Full Text] [Related]  

  • 8. Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
    Vannucchi AM; Kiladjian JJ; Griesshammer M; Masszi T; Durrant S; Passamonti F; Harrison CN; Pane F; Zachee P; Mesa R; He S; Jones MM; Garrett W; Li J; Pirron U; Habr D; Verstovsek S
    N Engl J Med; 2015 Jan; 372(5):426-35. PubMed ID: 25629741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?
    Beauverd Y; McLornan DP; Radia DH; Harrison CN
    Future Oncol; 2016 Mar; 12(6):739-49. PubMed ID: 26846873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.
    Verstovsek S; Vannucchi AM; Griesshammer M; Masszi T; Durrant S; Passamonti F; Harrison CN; Pane F; Zachee P; Kirito K; Besses C; Hino M; Moiraghi B; Miller CB; Cazzola M; Rosti V; Blau I; Mesa R; Jones MM; Zhen H; Li J; Francillard N; Habr D; Kiladjian JJ
    Haematologica; 2016 Jul; 101(7):821-9. PubMed ID: 27102499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene.
    Helbig G; Wichary R; Torba K; Kyrcz-Krzemień S
    Med Oncol; 2017 Mar; 34(3):31. PubMed ID: 28120162
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of the Hepatitis B Virus DNA during the Treatment of Polycythemia Vera with the JAK Kinase Inhibitor Ruxolitinib.
    Kirito K; Sakamoto M; Enomoto N
    Intern Med; 2016; 55(10):1341-4. PubMed ID: 27181544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of Janus kinase inhibitors in the treatment of hematological malignancies.
    Senkevitch E; Durum S
    Cytokine; 2017 Oct; 98():33-41. PubMed ID: 28277287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruxolitinib for the treatment of patients with polycythemia vera.
    Kiladjian JJ; Winton EF; Talpaz M; Verstovsek S
    Expert Rev Hematol; 2015 Aug; 8(4):391-401. PubMed ID: 25980454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies.
    Kiladjian JJ; Guglielmelli P; Griesshammer M; Saydam G; Masszi T; Durrant S; Passamonti F; Jones M; Zhen H; Li J; Gadbaw B; Perez Ronco J; Khan M; Verstovsek S
    Ann Hematol; 2018 Apr; 97(4):617-627. PubMed ID: 29396713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Amelioration of Myelofibrosis with Thrombocytopenia by a JAK1/2 Inhibitor, Ruxolitinib, in a Post-polycythemia Vera Myelofibrosis Patient with a JAK2 Exon 12 Mutation.
    Ikeda K; Ueda K; Sano T; Ogawa K; Ikezoe T; Hashimoto Y; Morishita S; Komatsu N; Ohto H; Takeishi Y
    Intern Med; 2017; 56(13):1705-1710. PubMed ID: 28674362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.
    Rotenberg C; Besnard V; Brillet PY; Giraudier S; Nunes H; Valeyre D
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361243
    [No Abstract]   [Full Text] [Related]  

  • 18. Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study.
    Vannucchi AM; Verstovsek S; Guglielmelli P; Griesshammer M; Burn TC; Naim A; Paranagama D; Marker M; Gadbaw B; Kiladjian JJ
    Ann Hematol; 2017 Jul; 96(7):1113-1120. PubMed ID: 28456851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruxolitinib Enhances Platelet Production in Patients With Thrombocytopenic Myelofibrosis.
    Grunwald MR; Spivak JL
    J Clin Oncol; 2016 Feb; 34(5):e38-40. PubMed ID: 24958831
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic leg ulceration associated with polycythemia vera responding to ruxolitinib (Jakafi(®)).
    Shanmugam VK; McNish S; Shara N; Hubley KJ; Kallakury B; Dunning DM; Attinger CE; Steinberg JS
    J Foot Ankle Surg; 2013; 52(6):781-5. PubMed ID: 23953278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.